Trump Administration's GRAS Notification Rule Closes Food Safety Transparency Loophole
Source: "The Trump admin is trying to make sure Americans know what is really in their food | Fox News." August 28, 2026. www.foxnews.com
The Gist
The authors argue that food companies should have to tell the FDA when they decide a new food ingredient is safe, instead of just deciding on their own and putting it on the market with no oversight. They point to a case where an untested ingredient (tara flour) made people sick as proof that the current 'honor system' isn't working, and say this simple notification requirement is common sense, not government overreach.
Conclusion
The Trump administration's proposed rule requiring food manufacturers to notify the FDA when they self-determine a new substance is 'Generally Recognized as Safe' (GRAS) is a necessary and non-controversial reform that should be supported.
Premises
- Americans have a right to know what is in their food, which requires transparent, science-based oversight of ingredients.
- Under the current system, manufacturers can self-determine GRAS status and introduce new substances into the food supply without notifying the FDA or the public, creating a regulatory blind spot.
- The FDA cannot effectively oversee food safety if it lacks advance knowledge of new substances entering the supply chain.
- Real-world harm has already occurred under the current loophole, as demonstrated by tara flour, which caused hundreds of illnesses and hospitalizations before being reviewed and found not to meet GRAS standards.
- The proposed rule would require the FDA to maintain a public list of GRAS notices, increasing transparency for researchers, regulators, and consumers.
- Responsible manufacturers who already prioritize transparency and safety are currently disadvantaged by competitors who exploit the notification loophole.
- The rule does not restrict consumer food choices but merely ensures manufacturers disclose information to the FDA, making it a reasonable, non-intrusive form of oversight.
Assumptions
- Mandatory FDA notification will meaningfully improve the FDA's ability to detect and act on unsafe substances before harm occurs.
- Manufacturers' self-determinations of GRAS status, even with notification, will be truthful and adequately substantiated.
- The FDA has sufficient resources and capacity to review and act on an increased volume of GRAS notifications.
- Increased transparency will not impose undue compliance burdens that disadvantage smaller manufacturers.
- The tara flour incident is representative of a broader pattern of risk under the current system, not an isolated case.
- Public disclosure of GRAS notices will translate into consumers actually using this information to make informed choices.